SEC Comment Letter for IGC Pharma, Inc. (IGC) (CIK 0001326205) (IGC) — Jul 17, 2014
IGC Pharma, Inc. (IGC) (CIK 0001326205)
Date: July 17, 2014 · CIK: 0001326205 · Accession: 0000000000-14-036204
AI Filing Summary & Sentiment
Show Raw Text
July 1 7, 2014 Via E -mail Ram Mukunda Chief Executive Officer India Globalization Capital, Inc. 4336 Montgomery Ave. Bethesda, M D 20814 Re: India Globalization Capital , Inc. Form 10-K for the Fiscal Year Ended March 31 , 2013 Filed July 16 , 201 3 File No. 001 -32830 Dear Mr. Mukunda : We have comple ted our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/Tia L. Jenkins Tia L. Jenkins Senior Assistant Chief Accountant Office of Beverages, Apparel , and Mining